• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠肝脏线粒体的一种主要多肽成分:氨甲酰磷酸合成酶。

A major polypeptide component of rat liver mitochondria: carbamyl phosphate synthetase.

作者信息

Clarke S

出版信息

J Biol Chem. 1976 Feb 25;251(4):950-61.

PMID:175068
Abstract

One of the major components of rat liver mitochondria detected by gel electrophoresis in sodium dodecyl sulfate is a 165,000 molecular weight polypeptide that makes up 15 to 20% of the total mitochondrial protein. This component appears to be a single molecular species. Evidence is presented here for the identification of this protein with the polypeptide chain of a urea cycle enzyme, carbamoylphosphate synthetase I (EC 2.7.2.5). The 165,000 molecular weight polypeptide was solubilized from mitochondria with Triton X-100 and purified to 90% homogeneity by DEAE-cellulose chromatography. This component co-migrated with carbamyl phosphate synthetase activity when mitochondrial proteins were separated by gel filtration or sucrose gradient centifugation. The identification of the 165,000 molecular weight polypeptide with this activity was also supported by the presence or absence of this protein in a variety of rat tissue mitochondria, in liver and kidney mitochondria from various ureotelic and nonureotelic species, and in fetal rat liver mitochondria.

摘要

通过十二烷基硫酸钠凝胶电泳检测到的大鼠肝脏线粒体的主要成分之一是一种分子量为165,000的多肽,它占线粒体总蛋白的15%至20%。该成分似乎是单一分子种类。本文提供了证据,证明该蛋白质与尿素循环酶氨甲酰磷酸合成酶I(EC 2.7.2.5)的多肽链相同。用Triton X-100从线粒体中溶解出分子量为165,000的多肽,并通过DEAE-纤维素色谱法将其纯化至90%的同质性。当通过凝胶过滤或蔗糖梯度离心分离线粒体蛋白时,该成分与氨甲酰磷酸合成酶活性共同迁移。在多种大鼠组织线粒体、来自各种排尿素和非排尿素物种的肝脏和肾脏线粒体以及胎鼠肝脏线粒体中该蛋白质的存在与否,也支持了将分子量为165,000的多肽与该活性进行鉴定。

相似文献

1
A major polypeptide component of rat liver mitochondria: carbamyl phosphate synthetase.大鼠肝脏线粒体的一种主要多肽成分:氨甲酰磷酸合成酶。
J Biol Chem. 1976 Feb 25;251(4):950-61.
2
Purification, composition, and some properties of rat liver carbamyl phosphate synthetase (ammonia).大鼠肝脏氨甲酰磷酸合成酶(氨)的纯化、组成及某些性质
Arch Biochem Biophys. 1976 Jul;175(1):270-8. doi: 10.1016/0003-9861(76)90508-7.
3
Carbamoylphosphate synthetase I of rat-liver mitochondria. Purification, properties, and polypeptide molecular weight.大鼠肝脏线粒体氨甲酰磷酸合成酶I。纯化、性质及多肽分子量
Eur J Biochem. 1978 Apr 17;85(2):373-83. doi: 10.1111/j.1432-1033.1978.tb12249.x.
4
Preparation of crystalline carbamyl phosphate synthetase-I from frog liver.从蛙肝中制备结晶氨甲酰磷酸合成酶-I
J Biol Chem. 1978 Nov 25;253(22):8337-9.
5
Human carbamoylphosphate synthetase I.人氨甲酰磷酸合成酶I
Enzyme. 1981;26(5):233-9. doi: 10.1159/000459184.
6
In vitro synthesis of a putative precursor to the mitochondrial enzyme, carbamyl phosphate synthetase.
J Biol Chem. 1979 May 10;254(9):3141-4.
7
Cell-free synthesis and processing of a putative precursor for mitochondrial carbamyl phosphate synthetase I of rat liver.大鼠肝脏线粒体氨甲酰磷酸合成酶I假定前体的无细胞合成与加工
Proc Natl Acad Sci U S A. 1979 Oct;76(10):5071-5. doi: 10.1073/pnas.76.10.5071.
8
The molecular structure and function of carbamyl phosphate synthetase I.氨甲酰磷酸合成酶I的分子结构与功能
Trans N Y Acad Sci. 1983;41:103-15. doi: 10.1111/j.2164-0947.1983.tb02791.x.
9
Turnover of carbamyl-phosphate synthase, of other mitochondrial enzymes and of rat tissues. Effect of diet and of thyroidectomy.氨甲酰磷酸合成酶、其他线粒体酶以及大鼠组织的周转率。饮食和甲状腺切除的影响。
Eur J Biochem. 1977 May 16;75(2):583-92. doi: 10.1111/j.1432-1033.1977.tb11558.x.
10
Carbamoyl phosphate synthetase I of human liver. Purification, some properties and immunological cross-reactivity with the rat liver enzyme.人肝脏氨甲酰磷酸合成酶I。纯化、某些性质以及与大鼠肝脏酶的免疫交叉反应性。
Biochim Biophys Acta. 1981 May 14;659(1):150-60. doi: 10.1016/0005-2744(81)90279-5.

引用本文的文献

1
Hypoosmosis alters hepatocyte mitochondrial morphology and induces selective release of carbamoyl phosphate synthetase 1.低渗处理改变肝细胞线粒体形态,并诱导氨甲酰磷酸合成酶 1 的选择性释放。
Am J Physiol Gastrointest Liver Physiol. 2023 Oct 1;325(4):G334-G346. doi: 10.1152/ajpgi.00018.2023. Epub 2023 Jul 25.
2
Loss of mitochondrial fatty acid β-oxidation protein short-chain Enoyl-CoA hydratase disrupts oxidative phosphorylation protein complex stability and function.线粒体脂肪酸β-氧化蛋白短链烯酰基辅酶 A 水合酶缺失破坏氧化磷酸化蛋白复合物的稳定性和功能。
FEBS J. 2023 Jan;290(1):225-246. doi: 10.1111/febs.16595. Epub 2022 Aug 24.
3
Redox Activation of Mitochondrial DAMPs and the Metabolic Consequences for Development of Autoimmunity.
氧化还原激活线粒体 DAMPs 及其对自身免疫发展的代谢后果。
Antioxid Redox Signal. 2022 Mar;36(7-9):441-461. doi: 10.1089/ars.2021.0073.
4
The Effects of In Utero Fetal Hypoxia and Creatine Treatment on Mitochondrial Function in the Late Gestation Fetal Sheep Brain.宫内胎儿缺氧和肌酸治疗对晚期胎羊脑线粒体功能的影响。
Oxid Med Cell Longev. 2022 Jan 29;2022:3255296. doi: 10.1155/2022/3255296. eCollection 2022.
5
Mitochondrial Enzymes of the Urea Cycle Cluster at the Inner Mitochondrial Membrane.尿素循环的线粒体酶聚集在线粒体内膜。
Front Physiol. 2021 Jan 21;11:542950. doi: 10.3389/fphys.2020.542950. eCollection 2020.
6
CPS1: Looking at an ancient enzyme in a modern light.CPS1:用现代的眼光看待古老的酶。
Mol Genet Metab. 2020 Nov;131(3):289-298. doi: 10.1016/j.ymgme.2020.10.003. Epub 2020 Oct 10.
7
Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency.AAV 介导的基因治疗在瓜氨酸合成酶 1 缺乏症的小鼠模型中恢复尿素生成。
Mol Ther. 2020 Jul 8;28(7):1717-1730. doi: 10.1016/j.ymthe.2020.04.011. Epub 2020 Apr 17.
8
Constitutive release of CPS1 in bile and its role as a protective cytokine during acute liver injury.胆汁中 CPS1 的持续释放及其在急性肝损伤期间作为保护性细胞因子的作用。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9125-9134. doi: 10.1073/pnas.1822173116. Epub 2019 Apr 12.
9
A constitutive knockout of murine carbamoyl phosphate synthetase 1 results in death with marked hyperglutaminemia and hyperammonemia.鼠的氨基甲酰磷酸合成酶 1 的组成型敲除导致明显的高血氨症和高血氨血症,并伴有死亡。
J Inherit Metab Dis. 2019 Nov;42(6):1044-1053. doi: 10.1002/jimd.12048. Epub 2019 Mar 5.
10
Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy.条件性敲除小鼠肝脏中的氨甲酰磷酸合成酶 1 可导致高氨血症而无乳清酸尿症,肝靶向基因治疗可纠正该缺陷。
Mol Genet Metab. 2018 Aug;124(4):243-253. doi: 10.1016/j.ymgme.2018.04.001. Epub 2018 Apr 12.